Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Leptin and renal disease.

Libbie P Briley1, Lynda A Szczech

  • 1Division of Nephrology, Department of Internal Medicine, Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina 27710, USA. Brile003@mc.duke.edu

Seminars in Dialysis
|January 21, 2006
PubMed
Summary

Leptin, a key metabolic hormone, is increasingly recognized for its inflammatory role in kidney disease. This review explores leptin

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Oral Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor Roxadustat (FG-4592) for the Treatment of Anemia in Patients with CKD.

Clinical journal of the American Society of Nephrology : CJASN·2016
Same author

Primary care detection of chronic kidney disease in adults with type-2 diabetes: the ADD-CKD Study (awareness, detection and drug therapy in type 2 diabetes and chronic kidney disease).

PloS one·2014
Same author

Cardiovascular toxicity of epoetin-alfa in patients with chronic kidney disease.

American journal of nephrology·2013
Same author

Patient and caregiver knowledge and utilization of partial versus radical nephrectomy: results of a national kidney foundation survey to assess educational needs of kidney cancer patients and caregivers.

American journal of kidney diseases : the official journal of the National Kidney Foundation·2013
Same author

A decade after the KDOQI CKD guidelines: impact on the National Kidney Foundation.

American journal of kidney diseases : the official journal of the National Kidney Foundation·2012
Same author

Restless legs syndrome reported by incident haemodialysis patients: is treatment time of day relevant?

Nephrology (Carlton, Vic.)·2012

Area of Science:

  • Endocrinology and Nephrology
  • Molecular mechanisms of metabolic disease

Background:

  • Leptin is a crucial hormone regulating metabolism and energy balance.
  • Emerging evidence suggests leptin's involvement in inflammatory processes within the kidneys.
  • The role of leptin in uremia-associated cachexia is a growing area of interest for nephrologists.

Purpose of the Study:

  • To review the complex pathophysiology of the uremic state.
  • To discuss the historical discovery and physiological functions of leptin.
  • To elucidate the potential impact of leptin on kidney disease progression and end-stage renal disease outcomes.

Main Methods:

  • Literature review of existing studies on leptin, metabolism, and renal disease.
  • Analysis of the physiological roles of leptin in various organ systems.
  • Synthesis of current understanding regarding leptin's interaction with kidney disease progression and uremia.

Main Results:

  • Leptin's dual role as an energy store mediator and a potential inflammatory agent in renal disease is highlighted.
  • The review details the intricate relationship between leptin and the uremic environment.
  • Potential links between leptin levels and the morbidity/mortality associated with end-stage renal disease are explored.

Conclusions:

  • Leptin represents a significant molecule for nephrological research due to its multifaceted roles.
  • Understanding leptin's interactions is vital for managing kidney disease progression and improving patient outcomes.
  • Further investigation into leptin's inflammatory and metabolic effects in renal disease is warranted.

Related Experiment Videos